Levent Tabak
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
-
- Sarcoidosis and Beryllium Toxicity Research 5
- Co-authors
- Zeki Kılıçaslan (5 shared papers)Mustafa Erelel (2 shared papers)Çağlar Çuhadaroğlu (1 shared paper)Dilek Yılmazbayhan (4 shared papers)Gerhard Hoheisel (1 shared paper)Feyza Erkan (2 shared papers)Esen Kıyan (7 shared papers)Ulrich Costabel (1 shared paper)
In The Last Decade
Levent Tabak
22 papers receiving 251 citations
Peers
Comparison fields: 5 of 73
- Internal Medicine 29
- Infectious Diseases 101
- Hematology 34
- Neurology 38
- Reproductive Medicine 19
Countries citing papers authored by Levent Tabak
This map shows the geographic impact of Levent Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Tabak more than expected).
Fields of papers citing papers by Levent Tabak
This network shows the impact of papers produced by Levent Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Tabak. The network helps show where Levent Tabak may publish in the future.
Co-authors
The 25 scholars most cited alongside Levent Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 48 | |
| 2 | 1994 | 47 | |
| 3 | 2020 | 35 | |
| 4 | 2021 | 29 | |
| 5 | 2007 | 22 | |
| 6 | 1994 | 17 | |
| 7 | 2002 | 12 | |
| 8 | 2002 | 10 | |
| 9 | The value of labial biopsy in the differentiation of sarcoidosis from tuberculosis. | 2001 | 8 |
| 10 | 2016 | 5 | |
| 11 | 2007 | 5 | |
| 12 | 2014 | 4 | |
| 13 | 2005 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2015 | 2 | |
| 17 | INHERITED THROMBOPHILIC RISK FACTORS IN VENOUSTHROMBOEMBOLISM: FACTOR V LEIDEN AND PROTHROMBIN 20210 A | 2004 | 2 |
| 18 | 2018 | 1 | |
| 19 | Comparison of three clinical scoring methods in patients with pulmonary thromboembolism. | 2009 | 1 |
| 20 | 2011 | 1 |
About Levent Tabak
Levent Tabak is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Hematology, Infectious Diseases and Internal Medicine, having authored 24 papers that have together received 263 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Long-Term Effects of COVID-19 (2 papers), COVID-19 Clinical Research Studies (2 papers), Endometriosis Research and Treatment (2 papers) and Uterine Myomas and Treatments (2 papers). The work is most often cited by research in Internal Medicine (29 citations), Infectious Diseases (101 citations), Hematology (34 citations), Neurology (38 citations) and Reproductive Medicine (19 citations). Levent Tabak has collaborated with scholars based in Türkiye, Sweden and Norway. Frequent co-authors include Zeki Kılıçaslan, Mustafa Erelel, Çağlar Çuhadaroğlu, Dilek Yılmazbayhan, Gerhard Hoheisel, Feyza Erkan, Esen Kıyan, Ulrich Costabel, Helmut Teschler and Benan Çağlayan. Their work appears in journals such as Acta Radiologica, International Journal of Infectious Diseases, European Respiratory Journal, Annals of the American Thoracic Society and Journal of Asthma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.